Taurine chloramine inhibition of cell proliferation and cytokine production by rheumatoid arthritis fibroblast-like synoviocytes

Arthritis and Rheumatism

Volumn 42, Issue 12, 1999, Pages 2552-2560

  Kontny, Ewa ^a   Grabowska, Agnieszka ^b   Kowalczewski, Jacek ^a   Kurowska, Mariola ^a   Janicka, Iwona ^a   Marcinkiewicz, Janusz ^b   Maśliński, Włodzimierz ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TAURINE; TAURINE CHLORAMINE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SYNTHESIS; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CELL DIVISION; FEMALE; FIBROBLASTS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; SYNOVIAL MEMBRANE; TAURINE; TIME FACTORS;

EID: 0033507175     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199912)42:12<2552::AID-ANR7>3.0.CO;2-V     Document Type: Article

References (40)

1. Firestein GS. Etiology and pathogcnesis of rheumatoid arthritis. In: Kelley WN, Ruddy S, Harris ED, Sledge CB, editors. Textbook of rheumatology. Fifth edition. Philadelphia: Saunders; 1997. p. 851-97.
2. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
3. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yaha S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996;183:2593-603.
4. Chabaud M, Fossiez F, Taupin JL, Miossec P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by TH2 cytokines. J Immunol 1998;161:409-14.
5. Melnyk VO, Shipley GD, Sternfeld MD, Sherman L, Rosenbaum JT. Synoviocytes synthesize, bind, and respond to basic fibroblast growth factor. Arthritis Rheum 1990;33:493-500.
6. Remmers EF, Sano H, Lafayatis R, Case JP, Kumkumian GK, Hla T, et al. Production of platelet derived growth factor B chain (PDGF-B/c-sis) mRNA and immunoreactive PDGF B-like polypeptide by rheumatoid synovium: coexpression with heparin binding acid fibroblast growth factor-1. J Rheumatol 1991;18:7-13.
7. Suzuki H, Sugiyama E, Tunru IS, Yamashita N, Matsuno H, Hamazaki T, et al. Suppressive effect of interleukin-4 (IL-4) on IL-6 production by adherent rheumatoid synovial cells. Clin Immunol Immunopathol 1993;66:67-72.
8. Mihara M, Moriya Y, Kishomoto T, Oshugi Y. Interleukin-6 (IL-6) induces proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 1995;34:321-5.
9. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, et al. Soluble interleukin-6-receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A 1993;90: 11924-8.
10. Badolato R, Oppenheim JJ. Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis. Semin Arthritis Rheum 1996;26:526-38.
11. Paleolog EM. Angiogenesis: a critical process in the pathogenesis of RA - a role for VEGF? Br J Rheumatol 1996;35:917-20.
12. Firestein GS. Novel therapeutic strategies involving animals, arthritis, and apoptosis. Curr Opin Rheumatol 1998;10:236-41.
13. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
14. Moreland LW, Heck LW Jr, Koopman WJ. Biologic agents for treating rheumatoid arthritis: concepts and progress. Arthritis Rheum 1997;40:397-409.
15. Marcinkiewicz J. Neutrophil chloramines: missing links between innate and acquired immunity. Immunol Today 1997;18:577-80.
16. Edwards SW, Hallett MB. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol Today 1997;18:320-4.
17. Trang LE, Furst P, Odeback AC, Lovgren O. Plasma amino acids in rheumatoid arthritis. Scand J Rheumatol 1985;14:393-402.
18. Rylance HJ. Hypertaurinuria in rheumatoid arthritis. Ann Rheum Dis 1969;28:41-4.
19. Marcinkiewicz J, Grabowska A, Bereta J, Stelmaszynska T. Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leukoc Biol 1995;58:667-74.
20. Marcinkiewicz J, Grabowska A, Bereta J, Bryniarski K, Nowak B. Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 1998; 40:27-38.
21. Park E, Quinn MR, Wright CE, Schuller-Levis G. Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J Leukoc Biol 1993;54:119-24.
22. Kim C, Park E, Quinn MR, Schuller-Levis G. The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-α in the conditioned media is inhibited by taurine chloramine. Immunopharmacology 1996;34: 89-95.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol 1977;18:481-91.
25. Kontny E, Ziolkowska M, Ryzewska A, Maslinski W. Protein kinase C-dependent pathway is critical for the production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). Cytokine. In press.
26. Learn DB, Fried VA, Thomas EL. Taurine and hypotaurine content in human leukocytes. J Leukoc Biol 1990;48:174-82.
27. Grisham MB, Jefferson MM, Melton DF, Thomas EL. Chlorination of endogenous amines by isolated neutrophils: ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J Biol Chem 1984;259:10404-13.
28. Park E, Schuller-Levis G, Quinn MR. Taurine chloramine inhibits production of nitric oxide and TNF-α in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 1995;154:4778-84.
29. Park E, Schuller-Levis G, Jia JH, Quinn MR. Preactivation exposure of RAW 264.7 cells to taurine chloramine attenuates subsequent production of nitric oxide and expression of iNOS mRNA. J Leukoc Biol 1997;61:161-6.
30. 2 production in activated RAW 264.7 cells by post-transcriptional effects on inducible cyclooxygenase expression. Immunol Lett 1996;50:185-8.
31. Migita K, Eguchi K, Aoyagi T, Tsukada T, Tsuboi M, Kawabe Y, et al. The effects of the immunosuppressant rapamycin on the growth of rheumatoid arthritis (RA) synovial fibroblast. Clin Exp Immunol 1996;104:86-91.
32. Morita Y, Kashihara N, Yamamura M, Okamoto H, Harada S, Maeshima Y, et al. Inhibition of rheumatoid synovial fibroblast proliferation by antisense oligonucleotides targeting proliferating cell nuclear antigen messenger RNA. Arthritis Rheum 1997;40: 1292-7.
33. 2+ concentration. J Cell Biol 1995;131:509-24.
34. 2-induced alteration. Am J Pathol 1986;125:585-600.
35. Wang QJ, Giri SN, Hyde DM, Nakashima JM. Effects of taurine on bleomycin-induced lung fibrosis in hamsters. Proc Soc Exp Biol Med 1989;190:330-8.
36. Wang Q, Hollinger MA, Giri SN. Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment. J Pharmacol Exp Ther 1992;262:121-32.
37. Stapleton PP, Redmond HP, Bouchier-Hayes DJ. Taurine and inflammation - a new approach to an old problem? J Leukoc Biol 1997;61:231-2.
38. Stapleton PP, Molloy AM, Rodgers S, Bloomfield FJ. Neutrophil taurine in psoriasis. Ir J Med Sci 1996;165:173-6.
39. McLoughlin DM, Stapleton PP, Bloomfield FJ. Influence of taurine and a substituted taurine on the respiratory burst pathway in the inflammatory response. Biochem Soc Trans 1991;19:73-9.
40. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998;41:1521-37.